Sanming medical reform: is it enough to cut the price of medicine?

In 2014, a series of measures of Sanming medical reform made Sanming medical reform famous Sanming took the lead in the implementation of the annual salary system for doctors and presidents, which has also become the focus of attention of doctors In fact, as of this year, Sanming medical reform has been implemented for nearly three years In the three years, what inspiration and impact does Sanming medical reform bring to China's medical reform and the pharmaceutical industry? Zhu hengpeng, director of the public policy research center of the Institute of economics, Chinese Academy of Social Sciences, gave relevant data answers at the 2014 annual conference of China's pharmaceutical circulation industry held on June 26 Sanming, a prefecture level city with more than 3 million people, had a two-year health insurance deficit before the medical reform Today, the current deficit of health insurance is not uncommon The ongoing scandals in the medical field accelerate the process of Sanming medical reform It is understood that before the implementation of medical reform, Sanming had eight presidents arrested for corruption It can be said that these two factors are the key to Sanming medical reform Zhu hengpeng: what signals should Sanming medical reform convey? According to the center for public policy research, Institute of economics, Chinese Academy of Social Sciences, 22 hospitals accounted for 47.29% of their drug revenue in 2011 before Sanming medical reform After two years of reform, in 2013, the medical revenue of 22 hospitals in Sanming was only 2.009 billion, accounting for 28.21% However, medical income increased to 1.442 billion, accounting for 71.79% We can see that the hospital's medical income has decreased by nearly 30%, and the medical income has increased, which seems to show that Sanming medical reform has achieved remarkable results Sanming medical reform is famous for its three important contents First of all, Sanming medical reform allows second selection and second bargaining of drugs This content is obviously in violation of the policy of the central competent department, and the second bargaining will be directly turned from dark to light, and put on the table, and 192 of the high-priced drugs will be directly cut off at the beginning of the medical reform, which is also one of the key factors to reduce the proportion of hospital medical income The "benchmark price" of drugs is one of the priorities of the national development and Reform Commission this year Sanming City, as the "star of medical reform", also indicated in October that it would pilot the benchmark price, which is based on the "lowest price of domestic generic drugs" In the short two years, the average medical price has doubled Zhu hengpeng said that this was the direct result of the second article of Sanming medical reform, which "significantly increased the price of medical services" The third article of Sanming medical reform is also the key to the transparency of doctors' remuneration Sanming paid doctors 3-5 times higher than the average social wage in accordance with the international practice At present, Sanming has reached the level of 3 times, allowing doctors to get their due remuneration for their work and making their lives more dignified In 2013, Sanming doctor's maximum annual salary, including discipline award, can reach more than 390000 Although from the data point of view, Sanming medical reform "cut medicine" and improve medical income make the current medical reform present a good situation However, Zhu hengpeng believes that Sanming medical reform has damaged the interests of pharmaceutical enterprises, and the proportion of hospital medical revenue has gone down However, the sales volume of pharmaceutical enterprises has also declined According to insiders, after Sanming medical reform, the local drug retail has dropped by nearly half If Sanming medical reform is carried out all over the country, it is conceivable that there will be a tragedy for pharmaceutical enterprises Therefore, while formulating the medical reform policy, we must not exclude the needs of pharmaceutical enterprises.